Clinical Efficacy of Radiotherapy Combined with Gefitinib in the Treat-ment of Patients with Non-small Cell Lung Cancer
Objective To explore the efficacy of radiotherapy combined with gefitinib in the treatment of patients with non-small cell lung cancer(NSCLC).Methods The clinical data of 94 patients with NSCLC admitted to Linyi Central Hospital from February 2021 to February 2023 were retrospectively selected and divided into two groups with 47 cases in each group by different treatment methods.The control group was treated with radiotherapy,and the study group was treated with radiotherapy combined with gefitinib.The clinical efficacy,serum tumor markers and T lympho-cyte levels were compared between the two groups.Results Compared with the control group,the clinical efficacy of the study group was higher,the levels of serum tumor markers were lower,and the changes of T lymphocyte levels were smaller,the differences were statistically significant(all P<0.05).Conclusion The application of radiotherapy combined with gefitinib in the treatment of patients has a high clinical effect,can improve their immune function.
NETL
NSTL
万方数据
